Aelis Farma SA (EPA: AELIS)
France
· Delayed Price · Currency is EUR 2.660
-0.020 (-0.75%)
Dec 3, 2024, 3:55 PM CET
Aelis Farma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 7.55 | 9.05 | 3.81 | 9.08 | - | 0.01 | Upgrade
|
| Other Revenue | 3.23 | 3.3 | 4.56 | 1.69 | 1.14 | - | Upgrade
|
| Revenue | 10.78 | 12.36 | 8.36 | 10.76 | 1.14 | 0.01 | Upgrade
|
| Revenue Growth (YoY) | 9.85% | 47.75% | -22.28% | 846.53% | 12746.01% | -77.85% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 3.13 | Upgrade
|
| Gross Profit | 10.78 | 12.36 | 8.36 | 10.76 | 1.14 | -3.13 | Upgrade
|
| Selling, General & Admin | 3.29 | 2.61 | 3.1 | 1.34 | 0.66 | 1.41 | Upgrade
|
| Research & Development | 15.18 | 16.21 | 13.79 | 6.87 | 3.39 | - | Upgrade
|
| Other Operating Expenses | - | - | - | - | -0.07 | -0.02 | Upgrade
|
| Operating Expenses | 18.47 | 18.82 | 16.89 | 8.21 | 3.98 | 1.39 | Upgrade
|
| Operating Income | -7.69 | -6.46 | -8.53 | 2.55 | -2.84 | -4.52 | Upgrade
|
| Interest Expense | -0.19 | -0.16 | -0.11 | -0.14 | -0.14 | -0.04 | Upgrade
|
| Interest & Investment Income | 0.47 | 0.42 | 0.05 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.35 | 1.09 | -0.01 | 0.72 | -0.02 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 0.03 | -5.69 | -1.38 | -0.05 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -7.03 | -5.08 | -14.29 | 1.76 | -3.04 | -4.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.82 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.03 | Upgrade
|
| Pretax Income | -7.03 | -5.08 | -14.29 | 1.76 | -3.04 | -3.71 | Upgrade
|
| Income Tax Expense | -0 | 0 | 0 | 1.19 | -0.96 | -0.79 | Upgrade
|
| Net Income | -7.03 | -5.08 | -14.29 | 0.57 | -2.09 | -2.92 | Upgrade
|
| Net Income to Common | -7.03 | -5.08 | -14.29 | 0.57 | -2.09 | -2.92 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 12 | 10 | 10 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 12 | 10 | 10 | 9 | Upgrade
|
| Shares Change (YoY) | 4.83% | 8.94% | 23.49% | 0.01% | 7.72% | 22.34% | Upgrade
|
| EPS (Basic) | -0.53 | -0.39 | -1.21 | 0.06 | -0.22 | -0.33 | Upgrade
|
| EPS (Diluted) | -0.53 | -0.39 | -1.21 | 0.06 | -0.22 | -0.33 | Upgrade
|
| Free Cash Flow | -13.27 | -13.05 | -13.09 | 18.76 | -2.51 | - | Upgrade
|
| Free Cash Flow Per Share | -1.00 | -1.01 | -1.11 | 1.96 | -0.26 | - | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -71.29% | -52.30% | -101.92% | 23.71% | -249.78% | -51057.12% | Upgrade
|
| Profit Margin | -65.19% | -41.09% | -170.83% | 5.33% | -183.47% | -32974.24% | Upgrade
|
| Free Cash Flow Margin | -123.05% | -105.58% | -156.48% | 174.29% | -221.02% | - | Upgrade
|
| EBITDA | -7.55 | -6.4 | -8.48 | 2.57 | -2.83 | -4.51 | Upgrade
|
| EBITDA Margin | -70.07% | -51.80% | -101.35% | 23.85% | -248.99% | - | Upgrade
|
| D&A For EBITDA | 0.13 | 0.06 | 0.05 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EBIT | -7.69 | -6.46 | -8.53 | 2.55 | -2.84 | -4.52 | Upgrade
|
| EBIT Margin | -71.29% | -52.30% | -101.92% | 23.71% | -249.78% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 67.37% | - | - | Upgrade
|
| Revenue as Reported | 10.78 | 12.36 | 8.36 | 10.76 | 1.14 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.